Asahi Kasei Medical
  • Contact Us
  • Font size: Small
  • Font size: Medium
  • Font size: Large
  • Corporate Information
  • Products
  • News
  • Our Approach to Business
  • Patients and Families

IMMUSORBA TR: Selective immunoadsorption for neurological diseases with easy to handle single use column



Neurological diseases(e.g., Myasthenia gravis, Guillain-Barré syndrome, Chronic inflammatory demyelinating polyneuropathy, Multiple sclerosis)

Features of IMMUSORBA TR-350 (L)

  • Therapeutic plasmapheresis by removing pathogenic substances (anti-acetylcholine receptor antibodies and immune complexes) from patient's plasma by selective adsorption.
  • No need for the replacement of plasma, minimizing the risk of infection with hepatitis, AIDS, etc.
  • Applicable to patients with protein allergy.

IMMUSORBA is a trademark of Asahi Kasei Medical Co., Ltd.



Contact Us

Please feel free to send us any questions you may have about our products and support.

Contact Us

Your Voice

Share your feelings and experiences when using our products.

Your Voice
Note: It might be required in your country that medical devices shall be officially registered and/or approved by an authorized organization. Please contact our representative in your region or contact us to confirm whether the listed products are approved for use. These information may contain general information on medical-related topics and is not meant to provide specialist advice or instructions concerning the products and services sold by Asahi Kasei Medical. Please contact us directly for special inquiries. You should not use this information for diagnosing a health problem or disease but should always consult your own physician.Contact us

Top of page